Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 19, 2013
Tolvaptan, an orally active non-peptide arginine vasopressin V2 receptor antagonist, reduces ascites in rats with chronic liver injuryToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2005
[Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma]Seiji Ito, Yasuhiro Kodera, Yoshinari Mochizuki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 2, 2002
Clinical relevance of telomerase activity in primary gastric lymphomaYasuhiro Kodera, Tsuneya Nakamura, Takashi Suzuki, et al.
Cardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.
Cardiovascular Drugs and Therapy|November 29, 2011
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failureToshiyuki Onogawa, Yuki Sakamoto, Shigeki Nakamura, et al.
World Journal of Surgery|April 10, 2010
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCRSeiji Ito, Yasuhiro Kodera, Yoshinari Mochizuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 30, 2004
[A phase I study of combination chemotherapy using TS-1 and pirarubicin (THP) for advanced gastric cancer]Yoshitaka Yamamura, Yasuhiro Kodera, Hiromi Tanemura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 6, 2007
Distribution of free cancer cells in the abdominal cavity suggests limitations of bursectomy as an essential component of radical surgery for gastric carcinomaYoshitaka Yamamura, Seiji Ito, Yoshinari Mochizuki, et al.
Journal of Pharmacological Sciences|January 23, 2004
Effects of OPC-51803, a novel, nonpeptide vasopressin V2-receptor agonist, on micturition frequency in Brattleboro and aged ratsShigeki Nakamura, Takahiro Hirano, Yoshitaka Yamamura, et al.
Endocrinology|April 16, 2005
Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremiaToshiki Miyazaki, Yoshitaka Yamamura, Toshiyuki Onogawa, et al.
Pageof 8